Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy

J Am Acad Dermatol. 2010 Oct;63(4):e83-4. doi: 10.1016/j.jaad.2009.09.035.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bevacizumab
  • Biopsy, Needle
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Facial Neoplasms / diagnosis
  • Facial Neoplasms / drug therapy*
  • Facial Neoplasms / pathology*
  • Follow-Up Studies
  • Hemangiosarcoma / diagnosis
  • Hemangiosarcoma / drug therapy*
  • Hemangiosarcoma / pathology*
  • Humans
  • Immunohistochemistry
  • Male
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Paclitaxel / administration & dosage
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Paclitaxel